WATCHMAN FLXTM
Program Impact

  

hospital administrator and physician

Built on the most studied and implanted LAAC device in the world, WATCHMAN FLX is designed to advance procedural performance and safety while expanding the treatable patient population

ADVANCE SAFETY

Prevent Additional Surgeries From Procedural Complications1

Fully Rounded Ball – Designed to safely advance and maneuver within the LAA

Dual-row precision anchors – Designed to provide optimal device engagement with LAA tissue for long‑term stability

*Occurrence of one of the following events between the time of implant and within 7 days following the procedure or by hospital discharge, whichever is later: all-cause death, ischemic stroke, systemic embolism, or device or procedure related events requiring open cardiac surgery or major endovascular intervention

ADVANCE PROCEDURAL PERFORMANCE

Treat More Patients With 35% Time Savings1,2

Full recapture, reposition and redeploy capabilities for precise placement

Quicker complete seal – 77% reduced metal and 80% more contact points for enhanced healing and sealing

*LAA closure at 12 months is defined as any pier-device flow with jet size <5mm per core laboratory-assessed TEE 

EXPAND THE TREATABLE PATIENT POPULATION

Protect More Patients3

*Implant success defined as successful delivery and release of a WATCHMAN FLX device into the LAA 

  1. Doshi, SK. Presented at HRS 2020.
  2. Reddy, VY et al. Circulation. 
  3. Ellis et al. AF Symposium 2020 abstract.